AHA ACLS PROVIDER FINAL ACTUAL VERIFIED EXAM | AMERICAN HEART ASSOCIATION | 2026/2027
VERIFIED Q&A | HEALTHCARE PROFESSIONALS AND ACLS CANDIDATES | AHA ACLS
AHA ACLS
PROVIDER
2026/2027
AHA ACLS Provider Final Actual Verified Exam
American Heart Association (AHA) - 2026/2027 Academic Year
2026/2027 Academic Year | Verified Q&A for Healthcare Professionals
and Advanced Cardiovascular Life Support Candidates | AHA ACLS |
150Q VERIFIED NEWEST EXAM RATIONALES
ACLS FINAL 2026/2027 AHA ACLS
INCLUDES:
• BLS, ACLS Algorithms, Cardiac Arrest, Bradycardia Tachycardia, ACS Stroke, ACLS
• Pharmacology, Airway Management, Team Dynamics, High-Quality CPR, ACLS
• 150 Verified Questions + Answers + Detailed Rationales | AHA ACLS Provider Final
• Professional Study Guide | Borders + Page Numbers | AHA 2026/2027 Edition
AHA ACLS Provider Final Actual Verified Exam | AHA | Not affiliated
Confidential Study Guide - Educational Purposes Only | 2026/2027 Edition
,BLS High-Quality CPR ACLS Algorithms Cardiac Arrest Bradycardia Tachycardia ACS Stroke AHA
Description: BLS Basic Life Support and high-quality CPR foundation AHA ACLS Provider Final Actual Verified Exam 2026/2027, high-quality CPR components rate
100-120 per minute compressions, depth adults 2-2.4 inches 5-6 cm children 2 inches 1/3 chest infants 1.5 inches, full recoil allow chest recoil, minimize interruptions less
than 10 seconds, avoid excessive ventilation 30:2 compression ventilation ratio one rescuer two rescuers, 2 rescuers switch every 2 minutes, C-A-B sequence
Compressions Airway Breathing, pulse check less than 10 seconds, AED Automated External Defibrillator use turn on attach pads analyze shock if advised resume CPR
immediately, ACLS cardiac arrest algorithm Adult Cardiac Arrest Algorithm 2020 AHA, VFib Ventricular Fibrillation chaotic irregular no pulse shockable rhythm treatment
immediate CPR defibrillation biphasic 120-200 J monophasic 360 J epinephrine 1 mg IV IO every 3-5 min amiodarone 300 mg bolus then 150 mg or lidocaine 1-1.5 mg per
kg, pulseless VT Ventricular Tachycardia wide complex no pulse same as VFib, asystole flat line non-shockable CPR epinephrine no defibrillation confirm 2 leads, PEA
Pulseless Electrical Activity organized rhythm no pulse non-shockable epinephrine, reversible causes Hs and Ts Hypovolemia Hypoxia Hydrogen ion acidosis Hyper hypo
kalemia Hypothermia Tension pneumothorax Tamponade cardiac Toxins Thrombosis pulmonary coronary, bradycardia and tachycardia algorithms bradycardia heart rate
less than 50 symptomatic hypotension altered mental chest pain, treatment atropine 1 mg IV q 3-5 min max 3 mg, if ineffective transcutaneous pacing or dopamine 2-10
mcg per kg per min or epinephrine 2-10 mcg per min infusion, tachycardia algorithm heart rate greater than 150 symptomatic, stable vs unstable, stable SVT
Supraventricular Tachycardia vagal adenosine 6 mg then 12 mg, stable VT amiodarone, unstable hypotension altered chest pain synchronized cardioversion 50-100 J SVT
100 J VT, ACS and stroke ACS Acute Coronary Syndrome chest pain MI, MONA not recommended routine oxygen only if hypoxic, aspirin 162-325 mg chew, nitroglycerin
0.4 mg SL chest pain, morphine pain, heparin, 12-lead ECG within 10 minutes STEMI ST Elevation MI criteria cath lab activation door to balloon less than 90 min,
Non-STEMI troponin, stroke assessment BEFAST Balance Eyes Face Arm Speech Time, Cincinnati Prehospital Stroke Scale facial droop arm drift speech, tPA tissue
plasminogen activator alteplase window 3-4.5 hours ischemic hemorrhagic exclusion CT, door to needle less than 60 min, AHA ACLS Provider.
ACLS Pharmacology Airway Management Team Dynamics Post-Arrest ECG Interpretation AHA ACLS
Description: ACLS pharmacology core drugs AHA ACLS Provider Final, epinephrine alpha beta adrenergic vasoconstrictor cardiac arrest 1 mg IV IO every 3-5 minutes no
max, infusion 2-10 mcg per min bradycardia hypotension post-ROSC, amiodarone antiarrhythmic class III VF pulseless VT 300 mg IV push first dose then 150 mg second,
infusion 1 mg per min 6 hours then 0.5, lidocaine alternative 1-1.5 mg per kg then 0.5-0.75, atropine anticholinergic symptomatic bradycardia 1 mg IV q 3-5 min max 3 mg
not for 2nd degree Type II or 3rd degree with wide QRS, magnesium sulfate Torsades de Pointes hypomagnesemia 1-2 g IV, adenosine SVT 6 mg rapid push then 12 mg
then 12 mg, dopamine 2-10 mcg per kg per min, norepinephrine 0.1-0.5 mcg per kg per min, airway management basic airway OPA Oropharyngeal Airway measure corner
mouth earlobe unconscious no gag, NPA Nasopharyngeal Airway conscious semiconscious measure nose earlobe, bag-mask ventilation 15 L oxygen 2 hands, advanced
airway Endotracheal Tube ET intubation confirmation waveform capnography ETCO2 End-Tidal CO2 gold standard 35-45 mmHg plus bilateral breath sounds, supraglottic
airways LMA Laryngeal Mask Airway King LT, suctioning, capnography waveform capnography normal rectangular, team dynamics ACLS high-performance team
closed-loop communication clear messages repeat back, clear roles leader compressor airway IV monitor defib, knowledge sharing, mutual respect, post-cardiac arrest
care and special situations ROSC Return of Spontaneous Circulation post-cardiac arrest care ABCDEFG Airway Breathing Circulation Disability Exposure Further care,
TTM Targeted Temperature Management 32-36 C for 24 hours comatose, hemodynamic support MAP greater than 65, oxygenation 92-98 percent, ventilation ETCO2
35-45, glucose control, neuroprognosis 72 hours, special situations pregnancy left uterine displacement manual 4-minute C-section if no ROSC, opioid overdose naloxone,
anaphylaxis epinephrine, asthma, ECG interpretation rhythms normal sinus rhythm rate 60-100 P before QRS regular, sinus bradycardia less than 60, sinus tachycardia
greater than 100, Ventricular Fibrillation chaotic irregular baseline no QRS, pulseless VT wide QRS greater than 120 rate greater than 150 no pulse, asystole flat line, PEA
organized QRS no pulse, SVT narrow QRS regular rate 150-250 no P, Atrial Fibrillation irregularly irregular no P, Ventricular Tachycardia wide monomorphic polymorphic
Torsades, intervals PR 0.12-0.20 QRS less than 0.12 QT, AHA ACLS Provider certification 2 years renewal BLS ACLS course 2 days skills written 50 questions 84 percent
passing 2020 AHA Guidelines 2025 Updates, AHA American Heart Association.
AHA ACLS Provider Final Exam Domains Healthcare Professionals Advanced Cardiovascular Candidates
Description: AHA ACLS Provider Final exam American Heart Association AHA ACLS Advanced Cardiovascular Life Support Provider 2026/2027 Academic Year, credential
AHA ACLS Provider certification healthcare professionals physicians nurses paramedics respiratory, eligibility BLS Provider current, exam blueprint domains BLS
High-Quality CPR 10 percent rate 100-120 depth 2-2.4 recoil interruptions 30:2 C-A-B AED, Cardiac Arrest Algorithm 25 percent VFib pulseless VT shockable CPR defib
120-200 J epinephrine 1 mg q 3-5 amiodarone 300 150 asystole PEA non-shockable Hs Ts reversible, Bradycardia Tachycardia Algorithms 15 percent bradycardia less
than 50 symptomatic atropine 1 mg max 3 pacing dopamine epinephrine infusion tachycardia stable unstable SVT adenosine 6 12 cardioversion 50-100 100-200, ACS
Stroke 15 percent MONA aspirin 325 nitro ECG STEMI door balloon 90 BEFAST tPA 3-4.5 door needle 60, Pharmacology 15 percent epinephrine 1 mg 2-10 mcg
amiodarone 300 150 lidocaine 1-1.5 atropine 1 mg magnesium 1-2 adenosine 6 12 dopamine, Airway Team Dynamics 10 percent OPA NPA bag-mask ET tube LMA
capnography waveform ETCO2 35-45 closed-loop clear roles, Post-Cardiac Arrest Special Situations 10 percent ROSC ABCDEFG TTM 32-36 MAP 65 pregnancy opioid,
ECG Interpretation 10 percent normal sinus VFib pulseless VT asystole PEA SVT AFib VT Torsades PR QRS QT, College Healthcare Professional Continuing Education,
study materials AHA ACLS Provider Manual 2020 AHA Guidelines, 2026/2027 academic year actual verified exam 150Q verified questions answers rationales for
healthcare professionals and advanced cardiovascular life support candidates, ACLS core BLS CPR 100-120 2-2.4 AED VFib VT shock 120-200 epi 1 mg q 3-5 amio 300
bradycardia atropine 1 mg pacing tachycardia SVT adenosine 6 12 cardioversion ACS aspirin STEMI 90 stroke BEFAST tPA 3-4.5 airway OPA NPA ET capnography
ETCO2 team closed-loop ROSC TTM ECG normal sinus VFib PEA SVT, healthcare professionals advanced cardiovascular life support candidates exam preparation, AHA
ACLS Provider Final Actual Verified Exam, study guide borders page numbers improved cover page confidential educational purposes, healthcare professionals and
advanced cardiovascular life support candidates exam preparation, American Heart Association AHA.
Page 2 - AHA ACLS Provider Final 150Q 2026/2027
,Question 1: Q1: BLS and high-quality CPR - chest compressions and AED?
A. BLS high-quality CPR rate 100-120 depth 2-2.4 inches recoil minimize interruptions, AED use, 30:2 ratio, C-A-B sequence
B. Only rate 100-120 BLS high-quality CPR
C. Only depth 2-2.4 BLS high-quality CPR
D. No C-A-B BLS high-quality CPR
CORRECT ANSWER: A. BLS high-quality CPR rate 100-120 depth 2-2.4 inches recoil minimize interruptions, AED use, 30:2 ratio, C-A-B
sequence
RATIONALE:
Rationale: BLS high-quality CPR rate 100-120 depth 2-2.4 inches recoil minimize interruptions, AED use, 30:2 ratio, C-A-B sequence. Per American Heart Association
AHA ACLS Provider guidelines 2020/2025 for healthcare professionals and advanced cardiovascular life support candidates 2026/2027.
Question 2: Q2: ACLS cardiac arrest algorithm - VFib pulseless VT asystole PEA?
A. Only asystole ACLS cardiac arrest algorithm
B. Only VFib ACLS cardiac arrest algorithm
C. ACLS cardiac arrest VFib pulseless VT shockable CPR epinephrine amiodarone, asystole PEA non-shockable epinephrine, Hs and Ts reversible
D. No Hs and Ts ACLS cardiac arrest algorithm
CORRECT ANSWER: C. ACLS cardiac arrest VFib pulseless VT shockable CPR epinephrine amiodarone, asystole PEA non-shockable
epinephrine, Hs and Ts reversible
RATIONALE:
Rationale: ACLS cardiac arrest VFib pulseless VT shockable CPR epinephrine amiodarone, asystole PEA non-shockable epinephrine, Hs and Ts reversible. Per
American Heart Association AHA ACLS Provider guidelines 2020/2025 for healthcare professionals and advanced cardiovascular life support candidates 2026/2027.
Question 3: Q3: Bradycardia and tachycardia algorithms - brady and tachy management?
A. Only SVT bradycardia tachycardia algorithms
B. Only atropine bradycardia tachycardia algorithms
C. No cardioversion bradycardia tachycardia algorithms
D. Bradycardia algorithm symptomatic bradycardia less than 50 atropine 1 mg transcutaneous pacing dopamine epinephrine, tachycardia stable unstable
SVT VT cardioversion
CORRECT ANSWER: D. Bradycardia algorithm symptomatic bradycardia less than 50 atropine 1 mg transcutaneous pacing dopamine
epinephrine, tachycardia stable unstable SVT VT cardioversion
RATIONALE:
Rationale: Bradycardia algorithm symptomatic bradycardia less than 50 atropine 1 mg transcutaneous pacing dopamine epinephrine, tachycardia stable unstable SVT VT
cardioversion. Per American Heart Association AHA ACLS Provider guidelines 2020/2025 for healthcare professionals and advanced cardiovascular life support
candidates 2026/2027.
Question 4: Q4: ACS and stroke - acute coronary syndrome and stroke management?
A. Only MONA ACS stroke
B. ACS Acute Coronary Syndrome MONA morphine oxygen nitroglycerin aspirin, 12-lead ECG STEMI cath lab, stroke BEFAST Cincinnati, tPA window,
door to needle
C. Only STEMI ACS stroke
D. No tPA ACS stroke
CORRECT ANSWER: B. ACS Acute Coronary Syndrome MONA morphine oxygen nitroglycerin aspirin, 12-lead ECG STEMI cath lab, stroke
BEFAST Cincinnati, tPA window, door to needle
RATIONALE:
Rationale: ACS Acute Coronary Syndrome MONA morphine oxygen nitroglycerin aspirin, 12-lead ECG STEMI cath lab, stroke BEFAST Cincinnati, tPA window, door to
needle. Per American Heart Association AHA ACLS Provider guidelines 2020/2025 for healthcare professionals and advanced cardiovascular life support candidates
2026/2027.
Question 5: Q5: ACLS pharmacology - epinephrine amiodarone atropine and drugs?
A. ACLS drugs epinephrine 1 mg q 3-5 min cardiac arrest 2-10 mcg per min infusion, amiodarone 300 mg 150 mg VF VT, atropine 1 mg bradycardia,
lidocaine, magnesium
B. Only epinephrine 1 mg ACLS pharmacology
C. Only amiodarone 300 mg ACLS pharmacology
D. No atropine ACLS pharmacology
CORRECT ANSWER: A. ACLS drugs epinephrine 1 mg q 3-5 min cardiac arrest 2-10 mcg per min infusion, amiodarone 300 mg 150 mg VF VT,
atropine 1 mg bradycardia, lidocaine, magnesium
RATIONALE:
Rationale: ACLS drugs epinephrine 1 mg q 3-5 min cardiac arrest 2-10 mcg per min infusion, amiodarone 300 mg 150 mg VF VT, atropine 1 mg bradycardia, lidocaine,
magnesium. Per American Heart Association AHA ACLS Provider guidelines 2020/2025 for healthcare professionals and advanced cardiovascular life support candidates
2026/2027.
Question 6: Q6: Airway management and team dynamics - advanced airway and team?
A. Only ET tube airway management team dynamics
B. Only OPA airway management team dynamics
C. Airway management basic OPA NPA bag-mask, advanced ET tube supraglottic LMA capnography waveform ETCO2, team dynamics closed-loop
clear roles
D. No capnography airway management team dynamics
CORRECT ANSWER: C. Airway management basic OPA NPA bag-mask, advanced ET tube supraglottic LMA capnography waveform ETCO2,
team dynamics closed-loop clear roles
RATIONALE:
Page 3 - AHA ACLS Provider Final 150Q 2026/2027
, Rationale: Airway management basic OPA NPA bag-mask, advanced ET tube supraglottic LMA capnography waveform ETCO2, team dynamics closed-loop clear roles.
Per American Heart Association AHA ACLS Provider guidelines 2020/2025 for healthcare professionals and advanced cardiovascular life support candidates 2026/2027.
Question 7: Q7: Post-cardiac arrest care and special situations - ROSC care?
A. Only TTM post-cardiac arrest care special situations
B. Only ROSC post-cardiac arrest care special situations
C. No pregnancy post-cardiac arrest care special situations
D. Post-cardiac arrest ROSC Return Spontaneous Circulation care ABCDEFG, TTM Targeted Temperature Management, hypotension vasopressor,
special situations pregnancy opioid overdose
CORRECT ANSWER: D. Post-cardiac arrest ROSC Return Spontaneous Circulation care ABCDEFG, TTM Targeted Temperature Management,
hypotension vasopressor, special situations pregnancy opioid overdose
RATIONALE:
Rationale: Post-cardiac arrest ROSC Return Spontaneous Circulation care ABCDEFG, TTM Targeted Temperature Management, hypotension vasopressor, special
situations pregnancy opioid overdose. Per American Heart Association AHA ACLS Provider guidelines 2020/2025 for healthcare professionals and advanced
cardiovascular life support candidates 2026/2027.
Question 8: Q8: ECG interpretation - rhythms and intervals?
A. Only normal sinus ECG interpretation
B. ECG interpretation rhythms normal sinus bradycardia tachycardia VFib pulseless VT asystole PEA SVT AFib VTorsades, intervals PR QRS QT
C. Only VFib ECG interpretation
D. No QT ECG interpretation
CORRECT ANSWER: B. ECG interpretation rhythms normal sinus bradycardia tachycardia VFib pulseless VT asystole PEA SVT AFib
VTorsades, intervals PR QRS QT
RATIONALE:
Rationale: ECG interpretation rhythms normal sinus bradycardia tachycardia VFib pulseless VT asystole PEA SVT AFib VTorsades, intervals PR QRS QT. Per American
Heart Association AHA ACLS Provider guidelines 2020/2025 for healthcare professionals and advanced cardiovascular life support candidates 2026/2027.
Question 9: Q9: AHA ACLS Provider - certification and guidelines?
A. AHA ACLS Provider certification 2 years, guidelines 2020 AHA Guidelines Updates 2025, BLS prerequisite, skills testing written exam 50 questions 84
percent passing
B. Only 2 years AHA ACLS Provider certification guidelines
C. Only 2020 Guidelines AHA ACLS Provider certification guidelines
D. No 84 percent AHA ACLS Provider certification guidelines
CORRECT ANSWER: A. AHA ACLS Provider certification 2 years, guidelines 2020 AHA Guidelines Updates 2025, BLS prerequisite, skills
testing written exam 50 questions 84 percent passing
RATIONALE:
Rationale: AHA ACLS Provider certification 2 years, guidelines 2020 AHA Guidelines Updates 2025, BLS prerequisite, skills testing written exam 50 questions 84 percent
passing. Per American Heart Association AHA ACLS Provider guidelines 2020/2025 for healthcare professionals and advanced cardiovascular life support candidates
2026/2027.
Question 10: Q10: AHA ACLS Provider Final domains - healthcare professionals candidates?
A. Only cardiac arrest AHA ACLS Provider Final domains
B. Only BLS AHA ACLS Provider Final domains
C. AHA ACLS Final domains BLS high-quality CPR 10 percent cardiac arrest VF VT asystole PEA 25 percent bradycardia tachycardia 15 percent ACS
stroke 15 percent pharmacology 15 percent airway team 10 percent post-arrest special 10 percent
D. No pharmacology AHA ACLS Provider Final domains
CORRECT ANSWER: C. AHA ACLS Final domains BLS high-quality CPR 10 percent cardiac arrest VF VT asystole PEA 25 percent bradycardia
tachycardia 15 percent ACS stroke 15 percent pharmacology 15 percent airway team 10 percent post-arrest special 10 percent
RATIONALE:
Rationale: AHA ACLS Final domains BLS high-quality CPR 10 percent cardiac arrest VF VT asystole PEA 25 percent bradycardia tachycardia 15 percent ACS stroke 15
percent pharmacology 15 percent airway team 10 percent post-arrest special 10 percent. Per American Heart Association AHA ACLS Provider guidelines 2020/2025 for
healthcare professionals and advanced cardiovascular life support candidates 2026/2027.
Page 4 - AHA ACLS Provider Final 150Q 2026/2027
VERIFIED Q&A | HEALTHCARE PROFESSIONALS AND ACLS CANDIDATES | AHA ACLS
AHA ACLS
PROVIDER
2026/2027
AHA ACLS Provider Final Actual Verified Exam
American Heart Association (AHA) - 2026/2027 Academic Year
2026/2027 Academic Year | Verified Q&A for Healthcare Professionals
and Advanced Cardiovascular Life Support Candidates | AHA ACLS |
150Q VERIFIED NEWEST EXAM RATIONALES
ACLS FINAL 2026/2027 AHA ACLS
INCLUDES:
• BLS, ACLS Algorithms, Cardiac Arrest, Bradycardia Tachycardia, ACS Stroke, ACLS
• Pharmacology, Airway Management, Team Dynamics, High-Quality CPR, ACLS
• 150 Verified Questions + Answers + Detailed Rationales | AHA ACLS Provider Final
• Professional Study Guide | Borders + Page Numbers | AHA 2026/2027 Edition
AHA ACLS Provider Final Actual Verified Exam | AHA | Not affiliated
Confidential Study Guide - Educational Purposes Only | 2026/2027 Edition
,BLS High-Quality CPR ACLS Algorithms Cardiac Arrest Bradycardia Tachycardia ACS Stroke AHA
Description: BLS Basic Life Support and high-quality CPR foundation AHA ACLS Provider Final Actual Verified Exam 2026/2027, high-quality CPR components rate
100-120 per minute compressions, depth adults 2-2.4 inches 5-6 cm children 2 inches 1/3 chest infants 1.5 inches, full recoil allow chest recoil, minimize interruptions less
than 10 seconds, avoid excessive ventilation 30:2 compression ventilation ratio one rescuer two rescuers, 2 rescuers switch every 2 minutes, C-A-B sequence
Compressions Airway Breathing, pulse check less than 10 seconds, AED Automated External Defibrillator use turn on attach pads analyze shock if advised resume CPR
immediately, ACLS cardiac arrest algorithm Adult Cardiac Arrest Algorithm 2020 AHA, VFib Ventricular Fibrillation chaotic irregular no pulse shockable rhythm treatment
immediate CPR defibrillation biphasic 120-200 J monophasic 360 J epinephrine 1 mg IV IO every 3-5 min amiodarone 300 mg bolus then 150 mg or lidocaine 1-1.5 mg per
kg, pulseless VT Ventricular Tachycardia wide complex no pulse same as VFib, asystole flat line non-shockable CPR epinephrine no defibrillation confirm 2 leads, PEA
Pulseless Electrical Activity organized rhythm no pulse non-shockable epinephrine, reversible causes Hs and Ts Hypovolemia Hypoxia Hydrogen ion acidosis Hyper hypo
kalemia Hypothermia Tension pneumothorax Tamponade cardiac Toxins Thrombosis pulmonary coronary, bradycardia and tachycardia algorithms bradycardia heart rate
less than 50 symptomatic hypotension altered mental chest pain, treatment atropine 1 mg IV q 3-5 min max 3 mg, if ineffective transcutaneous pacing or dopamine 2-10
mcg per kg per min or epinephrine 2-10 mcg per min infusion, tachycardia algorithm heart rate greater than 150 symptomatic, stable vs unstable, stable SVT
Supraventricular Tachycardia vagal adenosine 6 mg then 12 mg, stable VT amiodarone, unstable hypotension altered chest pain synchronized cardioversion 50-100 J SVT
100 J VT, ACS and stroke ACS Acute Coronary Syndrome chest pain MI, MONA not recommended routine oxygen only if hypoxic, aspirin 162-325 mg chew, nitroglycerin
0.4 mg SL chest pain, morphine pain, heparin, 12-lead ECG within 10 minutes STEMI ST Elevation MI criteria cath lab activation door to balloon less than 90 min,
Non-STEMI troponin, stroke assessment BEFAST Balance Eyes Face Arm Speech Time, Cincinnati Prehospital Stroke Scale facial droop arm drift speech, tPA tissue
plasminogen activator alteplase window 3-4.5 hours ischemic hemorrhagic exclusion CT, door to needle less than 60 min, AHA ACLS Provider.
ACLS Pharmacology Airway Management Team Dynamics Post-Arrest ECG Interpretation AHA ACLS
Description: ACLS pharmacology core drugs AHA ACLS Provider Final, epinephrine alpha beta adrenergic vasoconstrictor cardiac arrest 1 mg IV IO every 3-5 minutes no
max, infusion 2-10 mcg per min bradycardia hypotension post-ROSC, amiodarone antiarrhythmic class III VF pulseless VT 300 mg IV push first dose then 150 mg second,
infusion 1 mg per min 6 hours then 0.5, lidocaine alternative 1-1.5 mg per kg then 0.5-0.75, atropine anticholinergic symptomatic bradycardia 1 mg IV q 3-5 min max 3 mg
not for 2nd degree Type II or 3rd degree with wide QRS, magnesium sulfate Torsades de Pointes hypomagnesemia 1-2 g IV, adenosine SVT 6 mg rapid push then 12 mg
then 12 mg, dopamine 2-10 mcg per kg per min, norepinephrine 0.1-0.5 mcg per kg per min, airway management basic airway OPA Oropharyngeal Airway measure corner
mouth earlobe unconscious no gag, NPA Nasopharyngeal Airway conscious semiconscious measure nose earlobe, bag-mask ventilation 15 L oxygen 2 hands, advanced
airway Endotracheal Tube ET intubation confirmation waveform capnography ETCO2 End-Tidal CO2 gold standard 35-45 mmHg plus bilateral breath sounds, supraglottic
airways LMA Laryngeal Mask Airway King LT, suctioning, capnography waveform capnography normal rectangular, team dynamics ACLS high-performance team
closed-loop communication clear messages repeat back, clear roles leader compressor airway IV monitor defib, knowledge sharing, mutual respect, post-cardiac arrest
care and special situations ROSC Return of Spontaneous Circulation post-cardiac arrest care ABCDEFG Airway Breathing Circulation Disability Exposure Further care,
TTM Targeted Temperature Management 32-36 C for 24 hours comatose, hemodynamic support MAP greater than 65, oxygenation 92-98 percent, ventilation ETCO2
35-45, glucose control, neuroprognosis 72 hours, special situations pregnancy left uterine displacement manual 4-minute C-section if no ROSC, opioid overdose naloxone,
anaphylaxis epinephrine, asthma, ECG interpretation rhythms normal sinus rhythm rate 60-100 P before QRS regular, sinus bradycardia less than 60, sinus tachycardia
greater than 100, Ventricular Fibrillation chaotic irregular baseline no QRS, pulseless VT wide QRS greater than 120 rate greater than 150 no pulse, asystole flat line, PEA
organized QRS no pulse, SVT narrow QRS regular rate 150-250 no P, Atrial Fibrillation irregularly irregular no P, Ventricular Tachycardia wide monomorphic polymorphic
Torsades, intervals PR 0.12-0.20 QRS less than 0.12 QT, AHA ACLS Provider certification 2 years renewal BLS ACLS course 2 days skills written 50 questions 84 percent
passing 2020 AHA Guidelines 2025 Updates, AHA American Heart Association.
AHA ACLS Provider Final Exam Domains Healthcare Professionals Advanced Cardiovascular Candidates
Description: AHA ACLS Provider Final exam American Heart Association AHA ACLS Advanced Cardiovascular Life Support Provider 2026/2027 Academic Year, credential
AHA ACLS Provider certification healthcare professionals physicians nurses paramedics respiratory, eligibility BLS Provider current, exam blueprint domains BLS
High-Quality CPR 10 percent rate 100-120 depth 2-2.4 recoil interruptions 30:2 C-A-B AED, Cardiac Arrest Algorithm 25 percent VFib pulseless VT shockable CPR defib
120-200 J epinephrine 1 mg q 3-5 amiodarone 300 150 asystole PEA non-shockable Hs Ts reversible, Bradycardia Tachycardia Algorithms 15 percent bradycardia less
than 50 symptomatic atropine 1 mg max 3 pacing dopamine epinephrine infusion tachycardia stable unstable SVT adenosine 6 12 cardioversion 50-100 100-200, ACS
Stroke 15 percent MONA aspirin 325 nitro ECG STEMI door balloon 90 BEFAST tPA 3-4.5 door needle 60, Pharmacology 15 percent epinephrine 1 mg 2-10 mcg
amiodarone 300 150 lidocaine 1-1.5 atropine 1 mg magnesium 1-2 adenosine 6 12 dopamine, Airway Team Dynamics 10 percent OPA NPA bag-mask ET tube LMA
capnography waveform ETCO2 35-45 closed-loop clear roles, Post-Cardiac Arrest Special Situations 10 percent ROSC ABCDEFG TTM 32-36 MAP 65 pregnancy opioid,
ECG Interpretation 10 percent normal sinus VFib pulseless VT asystole PEA SVT AFib VT Torsades PR QRS QT, College Healthcare Professional Continuing Education,
study materials AHA ACLS Provider Manual 2020 AHA Guidelines, 2026/2027 academic year actual verified exam 150Q verified questions answers rationales for
healthcare professionals and advanced cardiovascular life support candidates, ACLS core BLS CPR 100-120 2-2.4 AED VFib VT shock 120-200 epi 1 mg q 3-5 amio 300
bradycardia atropine 1 mg pacing tachycardia SVT adenosine 6 12 cardioversion ACS aspirin STEMI 90 stroke BEFAST tPA 3-4.5 airway OPA NPA ET capnography
ETCO2 team closed-loop ROSC TTM ECG normal sinus VFib PEA SVT, healthcare professionals advanced cardiovascular life support candidates exam preparation, AHA
ACLS Provider Final Actual Verified Exam, study guide borders page numbers improved cover page confidential educational purposes, healthcare professionals and
advanced cardiovascular life support candidates exam preparation, American Heart Association AHA.
Page 2 - AHA ACLS Provider Final 150Q 2026/2027
,Question 1: Q1: BLS and high-quality CPR - chest compressions and AED?
A. BLS high-quality CPR rate 100-120 depth 2-2.4 inches recoil minimize interruptions, AED use, 30:2 ratio, C-A-B sequence
B. Only rate 100-120 BLS high-quality CPR
C. Only depth 2-2.4 BLS high-quality CPR
D. No C-A-B BLS high-quality CPR
CORRECT ANSWER: A. BLS high-quality CPR rate 100-120 depth 2-2.4 inches recoil minimize interruptions, AED use, 30:2 ratio, C-A-B
sequence
RATIONALE:
Rationale: BLS high-quality CPR rate 100-120 depth 2-2.4 inches recoil minimize interruptions, AED use, 30:2 ratio, C-A-B sequence. Per American Heart Association
AHA ACLS Provider guidelines 2020/2025 for healthcare professionals and advanced cardiovascular life support candidates 2026/2027.
Question 2: Q2: ACLS cardiac arrest algorithm - VFib pulseless VT asystole PEA?
A. Only asystole ACLS cardiac arrest algorithm
B. Only VFib ACLS cardiac arrest algorithm
C. ACLS cardiac arrest VFib pulseless VT shockable CPR epinephrine amiodarone, asystole PEA non-shockable epinephrine, Hs and Ts reversible
D. No Hs and Ts ACLS cardiac arrest algorithm
CORRECT ANSWER: C. ACLS cardiac arrest VFib pulseless VT shockable CPR epinephrine amiodarone, asystole PEA non-shockable
epinephrine, Hs and Ts reversible
RATIONALE:
Rationale: ACLS cardiac arrest VFib pulseless VT shockable CPR epinephrine amiodarone, asystole PEA non-shockable epinephrine, Hs and Ts reversible. Per
American Heart Association AHA ACLS Provider guidelines 2020/2025 for healthcare professionals and advanced cardiovascular life support candidates 2026/2027.
Question 3: Q3: Bradycardia and tachycardia algorithms - brady and tachy management?
A. Only SVT bradycardia tachycardia algorithms
B. Only atropine bradycardia tachycardia algorithms
C. No cardioversion bradycardia tachycardia algorithms
D. Bradycardia algorithm symptomatic bradycardia less than 50 atropine 1 mg transcutaneous pacing dopamine epinephrine, tachycardia stable unstable
SVT VT cardioversion
CORRECT ANSWER: D. Bradycardia algorithm symptomatic bradycardia less than 50 atropine 1 mg transcutaneous pacing dopamine
epinephrine, tachycardia stable unstable SVT VT cardioversion
RATIONALE:
Rationale: Bradycardia algorithm symptomatic bradycardia less than 50 atropine 1 mg transcutaneous pacing dopamine epinephrine, tachycardia stable unstable SVT VT
cardioversion. Per American Heart Association AHA ACLS Provider guidelines 2020/2025 for healthcare professionals and advanced cardiovascular life support
candidates 2026/2027.
Question 4: Q4: ACS and stroke - acute coronary syndrome and stroke management?
A. Only MONA ACS stroke
B. ACS Acute Coronary Syndrome MONA morphine oxygen nitroglycerin aspirin, 12-lead ECG STEMI cath lab, stroke BEFAST Cincinnati, tPA window,
door to needle
C. Only STEMI ACS stroke
D. No tPA ACS stroke
CORRECT ANSWER: B. ACS Acute Coronary Syndrome MONA morphine oxygen nitroglycerin aspirin, 12-lead ECG STEMI cath lab, stroke
BEFAST Cincinnati, tPA window, door to needle
RATIONALE:
Rationale: ACS Acute Coronary Syndrome MONA morphine oxygen nitroglycerin aspirin, 12-lead ECG STEMI cath lab, stroke BEFAST Cincinnati, tPA window, door to
needle. Per American Heart Association AHA ACLS Provider guidelines 2020/2025 for healthcare professionals and advanced cardiovascular life support candidates
2026/2027.
Question 5: Q5: ACLS pharmacology - epinephrine amiodarone atropine and drugs?
A. ACLS drugs epinephrine 1 mg q 3-5 min cardiac arrest 2-10 mcg per min infusion, amiodarone 300 mg 150 mg VF VT, atropine 1 mg bradycardia,
lidocaine, magnesium
B. Only epinephrine 1 mg ACLS pharmacology
C. Only amiodarone 300 mg ACLS pharmacology
D. No atropine ACLS pharmacology
CORRECT ANSWER: A. ACLS drugs epinephrine 1 mg q 3-5 min cardiac arrest 2-10 mcg per min infusion, amiodarone 300 mg 150 mg VF VT,
atropine 1 mg bradycardia, lidocaine, magnesium
RATIONALE:
Rationale: ACLS drugs epinephrine 1 mg q 3-5 min cardiac arrest 2-10 mcg per min infusion, amiodarone 300 mg 150 mg VF VT, atropine 1 mg bradycardia, lidocaine,
magnesium. Per American Heart Association AHA ACLS Provider guidelines 2020/2025 for healthcare professionals and advanced cardiovascular life support candidates
2026/2027.
Question 6: Q6: Airway management and team dynamics - advanced airway and team?
A. Only ET tube airway management team dynamics
B. Only OPA airway management team dynamics
C. Airway management basic OPA NPA bag-mask, advanced ET tube supraglottic LMA capnography waveform ETCO2, team dynamics closed-loop
clear roles
D. No capnography airway management team dynamics
CORRECT ANSWER: C. Airway management basic OPA NPA bag-mask, advanced ET tube supraglottic LMA capnography waveform ETCO2,
team dynamics closed-loop clear roles
RATIONALE:
Page 3 - AHA ACLS Provider Final 150Q 2026/2027
, Rationale: Airway management basic OPA NPA bag-mask, advanced ET tube supraglottic LMA capnography waveform ETCO2, team dynamics closed-loop clear roles.
Per American Heart Association AHA ACLS Provider guidelines 2020/2025 for healthcare professionals and advanced cardiovascular life support candidates 2026/2027.
Question 7: Q7: Post-cardiac arrest care and special situations - ROSC care?
A. Only TTM post-cardiac arrest care special situations
B. Only ROSC post-cardiac arrest care special situations
C. No pregnancy post-cardiac arrest care special situations
D. Post-cardiac arrest ROSC Return Spontaneous Circulation care ABCDEFG, TTM Targeted Temperature Management, hypotension vasopressor,
special situations pregnancy opioid overdose
CORRECT ANSWER: D. Post-cardiac arrest ROSC Return Spontaneous Circulation care ABCDEFG, TTM Targeted Temperature Management,
hypotension vasopressor, special situations pregnancy opioid overdose
RATIONALE:
Rationale: Post-cardiac arrest ROSC Return Spontaneous Circulation care ABCDEFG, TTM Targeted Temperature Management, hypotension vasopressor, special
situations pregnancy opioid overdose. Per American Heart Association AHA ACLS Provider guidelines 2020/2025 for healthcare professionals and advanced
cardiovascular life support candidates 2026/2027.
Question 8: Q8: ECG interpretation - rhythms and intervals?
A. Only normal sinus ECG interpretation
B. ECG interpretation rhythms normal sinus bradycardia tachycardia VFib pulseless VT asystole PEA SVT AFib VTorsades, intervals PR QRS QT
C. Only VFib ECG interpretation
D. No QT ECG interpretation
CORRECT ANSWER: B. ECG interpretation rhythms normal sinus bradycardia tachycardia VFib pulseless VT asystole PEA SVT AFib
VTorsades, intervals PR QRS QT
RATIONALE:
Rationale: ECG interpretation rhythms normal sinus bradycardia tachycardia VFib pulseless VT asystole PEA SVT AFib VTorsades, intervals PR QRS QT. Per American
Heart Association AHA ACLS Provider guidelines 2020/2025 for healthcare professionals and advanced cardiovascular life support candidates 2026/2027.
Question 9: Q9: AHA ACLS Provider - certification and guidelines?
A. AHA ACLS Provider certification 2 years, guidelines 2020 AHA Guidelines Updates 2025, BLS prerequisite, skills testing written exam 50 questions 84
percent passing
B. Only 2 years AHA ACLS Provider certification guidelines
C. Only 2020 Guidelines AHA ACLS Provider certification guidelines
D. No 84 percent AHA ACLS Provider certification guidelines
CORRECT ANSWER: A. AHA ACLS Provider certification 2 years, guidelines 2020 AHA Guidelines Updates 2025, BLS prerequisite, skills
testing written exam 50 questions 84 percent passing
RATIONALE:
Rationale: AHA ACLS Provider certification 2 years, guidelines 2020 AHA Guidelines Updates 2025, BLS prerequisite, skills testing written exam 50 questions 84 percent
passing. Per American Heart Association AHA ACLS Provider guidelines 2020/2025 for healthcare professionals and advanced cardiovascular life support candidates
2026/2027.
Question 10: Q10: AHA ACLS Provider Final domains - healthcare professionals candidates?
A. Only cardiac arrest AHA ACLS Provider Final domains
B. Only BLS AHA ACLS Provider Final domains
C. AHA ACLS Final domains BLS high-quality CPR 10 percent cardiac arrest VF VT asystole PEA 25 percent bradycardia tachycardia 15 percent ACS
stroke 15 percent pharmacology 15 percent airway team 10 percent post-arrest special 10 percent
D. No pharmacology AHA ACLS Provider Final domains
CORRECT ANSWER: C. AHA ACLS Final domains BLS high-quality CPR 10 percent cardiac arrest VF VT asystole PEA 25 percent bradycardia
tachycardia 15 percent ACS stroke 15 percent pharmacology 15 percent airway team 10 percent post-arrest special 10 percent
RATIONALE:
Rationale: AHA ACLS Final domains BLS high-quality CPR 10 percent cardiac arrest VF VT asystole PEA 25 percent bradycardia tachycardia 15 percent ACS stroke 15
percent pharmacology 15 percent airway team 10 percent post-arrest special 10 percent. Per American Heart Association AHA ACLS Provider guidelines 2020/2025 for
healthcare professionals and advanced cardiovascular life support candidates 2026/2027.
Page 4 - AHA ACLS Provider Final 150Q 2026/2027
